DBI-EPIbreath®
Revolutionizing Therapeutic Drug Monitoring
Key Features:
Non-Invasive Sampling
Requires only a simple exhalation, eliminating the need for blood draws.
Rapid Results
Delivers actionable insights within 10 minutes, facilitating timely clinical decisions.
Advanced Analytics
Utilizes machine learning algorithms to predict drug response and potential side effects.
Clinical Validation
Backed by peer-reviewed studies and CE-IVD certification in 2022, ensuring reliability and compliance.
Experience a new era in therapeutic drug monitoring with DBI-EPIbreath®
Please note that DBI-EPIbreath is currently not commercially available. If you are interested in evaluating the product for potential implementation in your clinic, we would be pleased to hear from you. Please feel free to contact us directly.
Partner & Customer
Deep Breath Intelligence (DBI) is a Swiss MedTech company using breath analysis and AI/ML for personalized health insights.
© All rights reserved, Deep Breath Intelligence - DBI, 2025. Website Design by 